A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

WEDNESDAY, Oct. 16, 2024 (HealthDay News) -- Obesity is a more powerful driver of breast cancer than previously thought, a ...

Health Secretary Wes Streeting believes these medications could be "life-changing" for individuals struggling with obesity.

Han is partnering with former KGI colleague Rachita Sumbria, now an associate professor in Chapman University’s School of Pharmacy, on this research. Han and Sumbria are completing a five-year grant ...

Transenteric delivery via the RaniPill yielded 80% relative bioavailability versus SC and differences between PK parameters ...

As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

Sep. 20, 2024 — A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease ...

Weight-loss jabs are “not the holy grail”, the NHS medical director has said ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence Halloween Trending searches ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal ...

Findings of eight-year study suggest the weight-loss jab could form ‘a novel therapeutic pathway’ in treating addiction ...